HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
7-Fluoro-1,2,3,4-tetrahydroquinoxalin-2-one
7-fluoro-3,4-dihydroquinoxalin-2(1H)-one · 2(1H)-Quinoxalinone, 7-fluoro-3,4-dihydro-

Identifikatoren & physikalische Daten
| CAS No. | 66367-11-1 |
|---|---|
| Summenformel | C8H7FN2O |
| Durchschnittliche Molmasse | 166,15 g/mol |
| Monoisotopische Masse | 166,05424101 g/mol |
| SMILES | O=C1CNc2ccc(F)cc2N1 |
| InChIKey | MKVHWJQPKMVYHA-UHFFFAOYSA-N |
| PubChem CID | 22912909 |
| EC No. | 855-545-4 |
Chemische & physikalische Eigenschaften
| XLogP | 1 |
|---|---|
| Polarare Oberfläche (TPSA) | 41,1 |
| H-Brücken-Donoren | 2 |
| H-Brücken-Akzeptoren | 3 |
| Frei drehbare Bindungen | 0 |
| Schwere Atome | 12 |
| Formalladung | 0 |
| Komplexität | 197 |
| Lagerbedingungen | 2-8°C, protect from light |
Sicherheit & Vorschriften
| GHS-Einstufung | WarningH302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposureRespiratory tract irritation]P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)The GHS information provided by 1 company from 1 notification to the ECHA C&L Inventory. |
|---|---|
| Hazard Classes and Categories | Acute Tox. 4 (100%)Skin Irrit. 2 (100%)Eye Irrit. 2A (100%)STOT SE 3 (100%) |
| Alarmwort | Warnung |
| Gefahrenhinweise | Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code H302 |
Anwendungen & Verwendung
Verwenden
7-Fluoro-3,4-dihydro-2(1H)-quinoxalinone a useful synthetic reagent and an impurity of 7-Fluoroquinoxalin-2(1H)-one (F596705), which is used in the development and optimization of novel bacterial topoisomerase type II inhibitors which show potential for use in development of antimicrobial agents against drug resistant pseudomonas aeruginosa.